Identification of optimal combination therapy partners for PI3K/Akt/mTOR pathway inhibitor in triple negative breast cancer

被引：0
|
作者：
Shariati, M. [1 ]
Paez-Arango, N. [1 ]
Bristow, C. A. [1 ]
Evans, K. W. [1 ]
Peoples, M. D. [1 ]
Carugo, A. [1 ]
Heffernan, T. P. [1 ]
Meric-Bernstam, F. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P6-18-13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-18-13
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PI3K/AKT/mTOR pathway inhibitors: the ideal combination partners for breast cancer therapies?
    Abraham, Jame
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (01) : 51 - 68
  • [2] Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
    Costa, Ricardo L. B.
    Han, Hyo Sook
    Gradishar, William J.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 169 (03) : 397 - 406
  • [3] Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
    Ricardo L. B. Costa
    Hyo Sook Han
    William J. Gradishar
    Breast Cancer Research and Treatment, 2018, 169 : 397 - 406
  • [4] Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy
    Cidado, Justin
    Park, Ben Ho
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2012, 17 (3-4) : 205 - 216
  • [5] Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy
    Justin Cidado
    Ben Ho Park
    Journal of Mammary Gland Biology and Neoplasia, 2012, 17 : 205 - 216
  • [6] Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway
    Massihnia, Daniela
    Galvano, Antonio
    Fanale, Daniele
    Perez, Alessandro
    Castiglia, Marta
    Incorvaia, Lorena
    Listi, Angela
    Rizzo, Sergio
    Cicero, Giuseppe
    Bazan, Viviana
    Castorina, Sergio
    Russo, Antonio
    ONCOTARGET, 2016, 7 (37) : 60712 - 60722
  • [7] PI3K/AKT/mTOR inhibitors for the management of triple-negative breast cancer
    Kadri Altundag
    Medical Oncology, 41 (11)
  • [8] Targeting PI3K/AKT pathway in triple-negative breast cancer
    Delaloge, Suzette
    DeForceville, Louise
    LANCET ONCOLOGY, 2017, 18 (10): : 1293 - 1294
  • [9] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [10] PI3K/Akt/mTOR pathway as a target for cancer therapy
    Morgensztern, D
    McLeod, HL
    ANTI-CANCER DRUGS, 2005, 16 (08) : 797 - 803
12345